Description

Methyl 1,2,3,7-Tetrahydro-8-Methyl-2-(2-Morpholinoethyl)Pyrrolo[3.2-F][1,3]Benzoxazine-9-Carboxylate is a sophisticated heterocyclic organic compound featuring a complex fused ring system with a morpholinoethyl substituent, making it a valuable advanced intermediate for pharmaceutical research and development. This compound is critical for medicinal chemists focused on synthesizing novel bioactive molecules, particularly those targeting central nervous system pathways. It is primarily utilized by R&D laboratories and pharmaceutical manufacturers engaged in the development of new therapeutic agents.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, especially for central nervous system (CNS) targets.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
• Preclinical Development: Serves as a critical intermediate for producing batches of experimental drugs for pharmacological and toxicological testing.
• Contract Research Organizations (CROs): Supplied to CROs supporting drug discovery programs for biotech and pharmaceutical clients.
• Academic Research: Utilized in university laboratories for studies on heterocyclic chemistry and the development of new synthetic methodologies.
• Reference Standard: Can be supplied as a high-purity standard for analytical method development and quality control in API synthesis.

Basic Information

Product Name	Methyl 1,2,3,7-Tetrahydro-8-Methyl-2-(2-Morpholinoethyl)Pyrrolo[3.2-F][1,3]Benzoxazine-9-Carboxylate
CAS No.	54436-08-7
Molecular Formula	C20H25N3O4
Molecular Weight	371.43 g/mol
Synonyms	Methyl 8-methyl-2-(2-morpholin-4-ylethyl)-1,2,3,7-tetrahydro-4H-pyrrolo[3,2-f][1,3]benzoxazine-9-carboxylate; 9H-Pyrrolo[3,2-f][1,3]benzoxazine-9-carboxylic acid, 1,2,3,7-tetrahydro-8-methyl-2-[2-(4-morpholinyl)ethyl]-, methyl ester; 54436-08-7; Methyl 1,2,3,7-tetrahydro-8-methyl-2-[2-(morpholin-4-yl)ethyl]pyrrolo[3,2-f][1,3]benzoxazine-9-carboxylate
EINECS	Contact for details

Quality Control

Our Methyl 1,2,3,7-Tetrahydro-8-Methyl-2-(2-Morpholinoethyl)Pyrrolo[3.2-F][1,3]Benzoxazine-9-Carboxylate is produced under strict quality management systems to ensure batch-to-batch consistency and high purity, suitable for demanding research applications. All products undergo rigorous analytical testing, including HPLC, NMR, and MS, to confirm identity and purity. Certificates of Analysis (COA) detailing all specifications are provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.